Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Clinician's Roundtable

Testicular Cancer: Raising Already Lofty Cure Rates

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Diagnosed in thousands of American men each year, testicular cancer has proven highly sensitive to current treatment regimens. Host Dr. Mark Nolan Hill evaluates the most common therapies for testicular cancer with Dr. Craig Nichols, medical director of lymphoma and testicular cancer research at Providence Portland Medical Center in Portland, Ore., and an internationally respected expert on testicular cancer. Are there significant side effects to the present therapies? Further, keeping in mind the possibility of a recurrent disease, and the accordant need for proper follow-up measures, Dr. Nichols evaluates strategies for coordinating care between medical oncologists and primary care physicians.

Recommended
Details
Presenters
Comments
  • Overview

    Diagnosed in thousands of American men each year, testicular cancer has proven highly sensitive to current treatment regimens. Host Dr. Mark Nolan Hill evaluates the most common therapies for testicular cancer with Dr. Craig Nichols, medical director of lymphoma and testicular cancer research at Providence Portland Medical Center in Portland, Ore., and an internationally respected expert on testicular cancer. Are there significant side effects to the present therapies? Further, keeping in mind the possibility of a recurrent disease, and the accordant need for proper follow-up measures, Dr. Nichols evaluates strategies for coordinating care between medical oncologists and primary care physicians.

Schedule2 Dec 2024